| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1037057045 |
| P356 | DOI | 10.1038/SREP16830 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/srep16830 |
| P932 | PMC publication ID | 4652178 |
| P698 | PubMed publication ID | 26582089 |
| P5875 | ResearchGate publication ID | 284185543 |
| P50 | author | Carlos Alberto Moreira-Filho | Q59690993 |
| Hátylas Azevedo | Q85489814 | ||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| The emerging paradigm of network medicine in the study of human disease | Q27026041 | ||
| Emergence of Scaling in Random Networks | Q27037290 | ||
| Human cancer protein-protein interaction network: a structural perspective | Q28472174 | ||
| Lethality and centrality in protein networks | Q29547267 | ||
| Error and attack tolerance of complex networks | Q29547268 | ||
| Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data | Q30804500 | ||
| Why do hubs tend to be essential in protein networks? | Q33245657 | ||
| MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival | Q33280922 | ||
| Identifying disease-specific genes based on their topological significance in protein networks | Q33421110 | ||
| PrognoScan: a new database for meta-analysis of the prognostic value of genes | Q33434943 | ||
| GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop | Q33711706 | ||
| clusterMaker: a multi-algorithm clustering plugin for Cytoscape | Q34070756 | ||
| Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance | Q34307356 | ||
| Attack robustness and centrality of complex networks | Q34657945 | ||
| Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool | Q34668270 | ||
| Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity | Q34675920 | ||
| Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells | Q34988108 | ||
| Analysis of candidate genes has proposed the role of y chromosome in human prostate cancer | Q35015903 | ||
| Protective properties of radio-chemoresistant glioblastoma stem cell clones are associated with metabolic adaptation to reduced glucose dependence. | Q35048997 | ||
| Computing topological parameters of biological networks. | Q51900389 | ||
| Downregulation of PAK5 inhibits glioma cell migration and invasion potentially through the PAK5-Egr1-MMP2 signaling pathway. | Q53089129 | ||
| Modular organization of cancer signaling networks is associated with patient survivability | Q62728415 | ||
| Attack vulnerability of complex networks | Q74282136 | ||
| Mechanisms of drug combinations: interaction and network perspectives | Q83265745 | ||
| GenCLiP 2.0: a web server for functional clustering of genes and construction of molecular networks based on free terms | Q87750481 | ||
| Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer | Q35134003 | ||
| Chemotherapeutic effect of tamoxifen on temozolomide-resistant gliomas | Q35533102 | ||
| Molecular signaling network complexity is correlated with cancer patient survivability | Q36061531 | ||
| A map of human cancer signaling | Q36327214 | ||
| Identifying critical transitions and their leading biomolecular networks in complex diseases | Q36455314 | ||
| Decoupling of DNA damage response signaling from DNA damages underlies temozolomide resistance in glioblastoma cells | Q36681945 | ||
| A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus | Q37308037 | ||
| Topological properties of protein interaction networks from a structural perspective | Q37330462 | ||
| A systems biology view of cancer | Q37434945 | ||
| Molecular mechanisms of temozolomide resistance in glioblastoma multiforme | Q38010801 | ||
| Interleukins in glioblastoma pathophysiology: implications for therapy. | Q38051761 | ||
| Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles | Q38093187 | ||
| Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma | Q38111449 | ||
| Glioblastoma and other malignant gliomas: a clinical review. | Q38160159 | ||
| Deciphering molecular determinants of chemotherapy in gastrointestinal malignancy using systems biology approaches | Q38209079 | ||
| Quantitative proteomic analysis and functional studies reveal that nucleophosmin is involved in cell death in glioblastoma cell line transfected with siRNA. | Q38496343 | ||
| TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells | Q38867558 | ||
| Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling | Q38916371 | ||
| Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas. | Q38925318 | ||
| MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells | Q38953118 | ||
| Overexpressed miRNA-137 inhibits human glioma cells growth by targeting Rac1. | Q39158791 | ||
| The microarray gene profiling analysis of glioblastoma cancer cells reveals genes affected by FAK inhibitor Y15 and combination of Y15 and temozolomide | Q39198605 | ||
| Rectifying cancer drug discovery through network pharmacology | Q39226874 | ||
| Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells | Q39352627 | ||
| STAT3 inhibition overcomes temozolomide resistance in glioblastoma by downregulating MGMT expression | Q39359062 | ||
| Inhibition of Aurora kinases enhances chemosensitivity to temozolomide and causes radiosensitization in glioblastoma cells. | Q39429784 | ||
| Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation | Q39450108 | ||
| Temozolomide-induced modification of the CXC chemokine network in experimental gliomas | Q39576881 | ||
| Gene expression profiling predicts response to temozolomide in malignant gliomas | Q39709566 | ||
| Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applications. | Q39720269 | ||
| Rational design of cancer-drug combinations | Q40106730 | ||
| Genetic alterations associated with acquired temozolomide resistance in SNB-19, a human glioma cell line | Q40229852 | ||
| Analyzing biological network parameters with CentiScaPe | Q41961222 | ||
| The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas | Q47605452 | ||
| MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells. | Q48595565 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemotherapy | Q974135 |
| P304 | page(s) | 16830 | |
| P577 | publication date | 2015-11-19 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Topological robustness analysis of protein interaction networks reveals key targets for overcoming chemotherapy resistance in glioma | |
| P478 | volume | 5 |
| Q38909947 | Construction of a Comprehensive Protein-Protein Interaction Map for Vitiligo Disease to Identify Key Regulatory Elements: A Systemic Approach |
| Q36473639 | Functional divergence and convergence between the transcript network and gene network in lung adenocarcinoma |
| Q49195059 | How the evolution of multicellularity set the stage for cancer. |
| Q54948646 | Identification of modules of hepatic encephalopathy based on protein-protein network and gene expression data. |
| Q95322476 | Metabolomics and Multi-Omics Integration: A Survey of Computational Methods and Resources |
| Q93005381 | Mining Featured Biomarkers Linked with Epithelial Ovarian CancerBased on Bioinformatics |
| Q58769130 | Minipuberty and Sexual Dimorphism in the Infant Human Thymus |
| Q92132838 | Modeling Basins of Attraction for Breast Cancer Using Hopfield Networks |
| Q39704507 | NIK regulates MT1-MMP activity and promotes glioma cell invasion independently of the canonical NF-κB pathway |
| Q29091067 | Network biology concepts in complex disease comorbidities |
| Q34523885 | PTIR: Predicted Tomato Interactome Resource |
| Q53180121 | Regulatory feedback loops bridge the human gene regulatory network and regulate carcinogenesis. |
| Q97561863 | Small-world networks of prognostic genes associated with lung adenocarcinoma development |
Search more.